Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lixian Yi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Science|September 19, 2025
Microbial and Metabolic Disorders in Cervical Cancer: Structural Insights, Biomarkers, Mechanisms, and Therapeutic StrategiesHong Tao, Luyu Wang, Yi Ding, et al.
Central-European Journal of Immunology|July 9, 2015
Enhancement of soluble CD28 levels in the serum of Graves' diseaseZhongwen Sun, Lixian Yi, Hong Tao, et al.
Analytica Chimica Acta|January 12, 2026
A transferrin-responsive fluorescent probe based on Zn-doped carbon dots for selective Fe<sup>3+</sup> detection in serumYuxin Tian, Lixian Yi, Ruhong Yan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2025
Targeting RNA Polymerase I Inhibits Ribosome Biogenesis to Block Liver Fibrosis ProgressionWei Luo, Lixian Yi, Yu Zhang, et al.
Hepatology International|November 12, 2025
Small extracellular vesicles derived from lipotoxic hepatocytes transport FASN to promote hepatic stellate cell activationYujie Shi, Lixian Yi, Yifei Chen, et al.
Inflammation|January 20, 2016
Correlation Between the Expression of MicroRNA-301a-3p and the Proportion of Th17 Cells in Patients with Rheumatoid ArthritisXinyi Tang, Kai Yin, Hongsheng Zhu, et al.
Oncoimmunology|February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironmentMin Yang, Wenwen Du, Lixian Yi, et al.
Cell Death & Disease|July 6, 2026
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockadeAlireza Labani-Motlagh, Yang Li, David Shihong Gao, et al.
Journal of Immunology Research|March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant TuberculosisPeijun Tang, Xingnian Chen, Junchi Xu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Science|September 19, 2025
Microbial and Metabolic Disorders in Cervical Cancer: Structural Insights, Biomarkers, Mechanisms, and Therapeutic StrategiesHong Tao, Luyu Wang, Yi Ding, et al.
Central-European Journal of Immunology|July 9, 2015
Enhancement of soluble CD28 levels in the serum of Graves' diseaseZhongwen Sun, Lixian Yi, Hong Tao, et al.
Analytica Chimica Acta|January 12, 2026
A transferrin-responsive fluorescent probe based on Zn-doped carbon dots for selective Fe<sup>3+</sup> detection in serumYuxin Tian, Lixian Yi, Ruhong Yan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 13, 2025
Targeting RNA Polymerase I Inhibits Ribosome Biogenesis to Block Liver Fibrosis ProgressionWei Luo, Lixian Yi, Yu Zhang, et al.
Hepatology International|November 12, 2025
Small extracellular vesicles derived from lipotoxic hepatocytes transport FASN to promote hepatic stellate cell activationYujie Shi, Lixian Yi, Yifei Chen, et al.
Inflammation|January 20, 2016
Correlation Between the Expression of MicroRNA-301a-3p and the Proportion of Th17 Cells in Patients with Rheumatoid ArthritisXinyi Tang, Kai Yin, Hongsheng Zhu, et al.
Oncoimmunology|February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironmentMin Yang, Wenwen Du, Lixian Yi, et al.
Cell Death & Disease|July 6, 2026
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockadeAlireza Labani-Motlagh, Yang Li, David Shihong Gao, et al.
Journal of Immunology Research|March 28, 2022
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant TuberculosisPeijun Tang, Xingnian Chen, Junchi Xu, et al.
Pageof 1